Sign inJoin waitlistJoin the waitlist

Rinath Jeselsohn

The Estrogen Receptor Mutations in Endocrine Resistance in Breast Cancer · Boston University Medical Center

Credentials: · · · ·

History

Boston University Medical Center
Present

Hematology and Medical Oncology
Tufts Medical Center
2004–2007
Internal Medicine
The University of Texas at Austin
2001–2004
Internal Medicine
UMass Chan Medical School
1998–2001
Hebrew University of Jerusalem Faculty of Medicine
1994–1998

Research

ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer
Review · Nature Reviews Clinical Oncology · 2015 · First of 5 authors · 570 citations
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer
Clinical Cancer Research · 2014 · Co-first of 31 authors · 549 citations
D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer
Cancer Research · 2013 · 337 citations

Myles Brown
30 papers
Sara Tolaney
24 papers
Nancy Lin
17 papers
Elizabeth Mittendorf
14 papers
Eric Winer
12 papers
Deborah Dillon
9 papers
Matthew Pun
8 papers · 1 as a resident
AF
Avery Feit
7 papers · 3 as a resident
Kent Osborne
7 papers
Daniel Abravanel
6 papers
Erica Mayer
6 papers
Mothaffar Rimawi
6 papers

Grants

Optimizing CDK7 Inhibitor Therapeutic Strategies for ER+ Breast Cancer
National Cancer Institute · R01
Contact PI · $2.3M · Dana-Farber Cancer Inst
2019–2031
Elucidating and Overcoming Endocrine Resistance Driven by ESR1 Mutations
National Cancer Institute · K08
Contact PI · $885.6K · Dana-Farber Cancer Inst
2015–2020